Balaxi Pharma

BALAXI30 Apr 2024

Trading

₹

+7.70 (+1.28%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Balaxi Pharma

Balaxi Pharma

Trading

BALAXI30 Apr 2024

₹

+7.70 (+1.28%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
23-May-2022	D	BALAXI PHARMACEUTICALS LIMITED has informed the Exchange that Board of Directors at its meeting held on 23-May-2022, declared Dividend of Rs. 0.50 per equity share. BALAXI PHARMACEUTICALS LIMITED has informed the Exchange that Record date for the purpose of Dividend is 04-Jul-2022. (As Per NSE Announcement Dated on 18/06/2022)	01-Jul-2022
15-Mar-2024	BC	Balaxi Pharmaceuticals Limited has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Notice of Postal	16-Apr-2024
09-Feb-2024	BC	To consider stock split of equity shares BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 28-Feb-2024 to consider and approve Stock split/Other business.	28-Feb-2024
02-Feb-2024	BC	To consider and approve the financial results for the period ended December 31, 2023 and other business matters BALAXI PHARMACEUTICALS LIMITED has submitted to the Exchange, the financial results	09-Feb-2024
26-Oct-2023	BC	To consider and approve the financial results for the period ended September 30, 2023 and other business matters BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Board meeting h	02-Nov-2023
29-May-2023	BC	BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Change in Director(s) of the company.	15-Sep-2023

No Rights has been declared by BALAXI

Book Closure

Record Date	Split Date	Purpose
16-Apr-2024	01 Jan'1900	Balaxi Pharmaceuticals Limited has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Notice of Postal
28-Feb-2024	-	To consider stock split of equity shares BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 28-Feb-2024 to consider and approve Stock split/Other business.
09-Feb-2024	-	To consider and approve the financial results for the period ended December 31, 2023 and other business matters BALAXI PHARMACEUTICALS LIMITED has submitted to the Exchange, the financial results
02-Nov-2023	-	To consider and approve the financial results for the period ended September 30, 2023 and other business matters BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Board meeting h
15-Sep-2023	-	BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Change in Director(s) of the company.

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Balaxi Pharmaceuticals Ltd ₹611.50(+7.70/1.28%)	611.50	+7.70	666.40	14.87	81.53	5.22
Integra Essentia Ltd ₹4.45(+0.20/4.71%)	4.45	+0.20	406.76	27.87	26.59	3.53
Kothari Products Ltd ₹136.25(+2.15/1.60%)	136.25	+2.15	406.62	18.27	81.01	0.42
Visagar Polytex Ltd ₹1.00(0.00/0.00%)	1.00	+0.00	29.27	11.11	0.00	1.82
Hexa Tradex Ltd ₹151.65(+0.60/0.40%)	151.65	+0.60	837.87	2.74	0.00	0.33
Future Consumer Ltd ₹0.90(0.00/0.00%)	0.90	+0.00	179.73	-25.00	0.00	-0.78

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	12.70	16.55	25.04	30.35	23.07	28.26
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	12.70	16.55	25.04	30.35	23.07	28.26
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	1.03	1.15	0.13	0.18	1.34	2.50
Total Income	13.73	17.70	25.17	30.53	24.41	30.77
Total Expenditure	12.42	15.64	21.27	24.95	19.50	24.74
PBIDT	1.31	2.07	3.90	5.58	4.91	6.03
Interest	0.41	0.36	0.26	0.23	0.01	0.02
PBDT	0.90	1.70	3.64	5.36	4.90	6.01
Depreciation	0.13	0.13	0.13	0.27	0.08	0.08
Tax	0.31	0.39	0.96	0.08	1.28	1.95
Deferred Tax	-0.03	0.00	0.00	1.07	0.00	0.00
Reported Profit After Tax	0.49	1.18	2.55	3.94	3.53	3.98
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.49	1.18	2.55	3.94	3.53	3.98

EPS (Unit Curr.)	0.48	1.16	2.50	3.90	3.52	3.98
EPS (Adj) (Unit Curr.)	0.48	1.16	2.50	3.90	3.52	3.98
Calculated EPS (Unit Curr.)	0.48	1.16	2.50	3.87	3.52	3.98
Calculated EPS (Adj) (Unit Curr.)	0.48	1.16	2.50	3.87	3.52	3.98
Calculated EPS (Ann.) (Unit Curr.)	1.91	4.62	9.99	15.49	14.09	15.91
Calculated EPS (Adj) (Ann.) (Unit Curr.)	1.91	4.62	9.99	15.49	14.09	15.91
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	10.23	10.23	10.23	10.18	10.02	10.00
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	10.31	12.51	15.58	18.39	21.28	21.34
PBDTM(%)	7.09	10.27	14.54	17.66	21.24	21.27
PATM(%)	3.86	7.13	10.18	12.98	15.30	14.08

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	60.79	54.72	65.96	80.68	86.58	86.38
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	60.79	54.72	65.96	80.68	86.58	86.38
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	1.51	5.93	-1.01	-0.22	-4.57	4.14
Total Income	62.29	60.65	64.95	80.46	82.02	90.52
Total Expenditure	47.13	43.96	103.78	67.94	71.29	71.63
PBIDT	15.17	16.69	-38.84	12.52	10.73	18.89
Interest	0.41	0.37	0.29	0.27	0.01	0.02
PBDT	14.75	16.32	-39.13	12.26	10.71	18.87
Depreciation	0.48	0.66	0.29	1.19	0.19	0.19
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.71	1.24	1.93	1.90	2.30	3.19
Deferred Tax	-0.03	0.00	0.00	1.07	0.00	0.00
Reported Profit After Tax	13.59	14.43	-41.34	8.10	8.23	15.49
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	13.59	14.43	-41.34	8.10	8.23	15.49

Extra-ordinary Items	1.56	5.20	-44.74	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	12.03	9.23	3.40	8.10	8.23	15.49

EPS (Unit Curr.)	13.29	14.10	-40.49	8.01	8.21	15.49
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	10.23	10.23	10.23	10.00	10.02	10.00

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	24.95	30.50	-58.88	15.52	12.39	21.87
PBDTM(%)	24.26	29.82	-59.32	15.20	12.37	21.85
PATM(%)	22.36	26.37	-62.67	10.04	9.51	17.93

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	10.18	10.00	10.00	10.00	3.04	3.04
Reserves Total	71.63	47.91	33.25	18.11	0.48	-1.49
Equity Share Warrants	10.30	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	92.11	57.91	43.25	28.11	3.52	1.55
Secured Loans	0.56	0.93	0.00	0.00	0.00	0.00
Unsecured Loans	11.87	1.00	3.51	0.00	0.00	0.00
Total Debt	12.43	1.93	3.51	0.00	0.00	0.00
Total Liabilities	104.54	59.84	46.76	28.11	3.52	1.55
APPLICATION OF FUNDS :
Gross Block	8.41	2.45	0.78	0.19	0.01	0.01
Less : Accumulated Depreciation	0.52	0.25	0.09	0.00	0.00	0.00
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	7.89	2.20	0.69	0.19	0.01	0.01
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	2.83	0.57	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	19.54	19.61	19.54	0.10	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	1.49	0.00	0.02	0.83	0.00	0.00
Sundry Debtors	78.29	52.11	48.13	31.22	5.47	0.00
Cash and Bank	17.88	0.84	0.48	3.57	0.13	1.65
Loans and Advances	1.36	1.12	0.05	1.08	0.17	0.00
Total Current Assets	99.02	54.08	48.67	36.70	5.78	1.65
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	19.57	17.28	16.72	7.38	2.12	0.13
Provisions	4.51	4.75	5.44	2.41	0.47	0.01
Total Current Liabilities	24.08	22.03	22.16	9.79	2.59	0.13
Net Current Assets	74.94	32.04	26.51	26.90	3.19	1.51
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	1.10	0.04	0.01	0.00	0.00	0.00
Net Deferred Tax	-1.10	-0.04	-0.01	0.00	0.00	0.00
Total Assets	104.11	54.38	46.73	27.19	3.20	1.52
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.84	0.47	3.55	0.10	1.62
Net Cash from Operating Activities	-7.07	8.89	13.46	-14.37	-1.51
Net Cash Used In Investing Activities	-2.29	-6.87	-20.03	-0.28	-0.01
Net Cash Used In Financing Activities	26.39	-1.64	3.49	18.10	0.00
Net Inc./Dec In Cash And Cash Equivalents	17.03	0.38	-3.08	3.44	-1.51
Cash And Cash Equivalents At End Of The Year	17.87	0.84	0.47	3.55	0.10

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

71.22%

FII Shareholding

18.57%

DII Shareholding

0.03%

Public Shareholding

10.18%

**Promoter pledged shareholding 71.22%

About Balaxi Pharmaceuticals Ltd

Balaxi Pharmaceuticals Ltd is in the Trading sector, having a market capitalization of Rs. 666.4 crores. It has reported a sales of Rs. 12.7 crores and a net profit of Rs. 0.49 crores for the quarter ended December 2018. The company management includes Ashish Maheshwari, Ashish Maheshwari,Minoshi Maheshwari,Kunal M Bhakta,Gandhi Gamji,M. Srinivas Rao,Purnima Singh Kamble (Balaxi Pharmaceuticals Ltd) among others.

Chairman

Ashish Maheshwari

Registered office

41/298-D2 2nd Flr Saniya Plaza,Mahakavi Bharatiyar Road,Cochin,Kerala,682035

FAX :

Background

Incorporation Year1942

Face Value₹10

Market Lot1

How to buy Balaxi Pharma shares on nse?

To buy Balaxi Pharma shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Balaxi Pharma share price today?

The Balaxi Pharma shares price on nse is Rs.611.5 today.

What is the market cap of Balaxi Pharma shares on NSE ?

The company has a market capitalization of Rs.666.40Cr

What is the PE & PB ratio of Balaxi Pharma shares ?

PE is 81.53 and PB is 5.22

What is the 52 Week High and Low of Balaxi Pharma shares?

Balaxi Pharma stock price high: Rs.686.3 Balaxi Pharma stock price low: Rs.399.95